| __timestamp | Alkermes plc | Madrigal Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 199905000 | 15746000 |
| Thursday, January 1, 2015 | 311558000 | 13392000 |
| Friday, January 1, 2016 | 374130000 | 9290000 |
| Sunday, January 1, 2017 | 421578000 | 7672000 |
| Monday, January 1, 2018 | 526408000 | 15293000 |
| Tuesday, January 1, 2019 | 599449000 | 22648000 |
| Wednesday, January 1, 2020 | 538827000 | 21864000 |
| Friday, January 1, 2021 | 560977000 | 37318000 |
| Saturday, January 1, 2022 | 605747000 | 48130000 |
| Sunday, January 1, 2023 | 689751000 | 108146000 |
| Monday, January 1, 2024 | 645238000 |
In pursuit of knowledge
In the competitive world of pharmaceuticals, managing costs is crucial for success. This chart compares the Selling, General, and Administrative (SG&A) expenses of Madrigal Pharmaceuticals, Inc. and Alkermes plc from 2014 to 2023. Over this period, Alkermes consistently outspent Madrigal, with its SG&A expenses growing by approximately 245%, from $200 million in 2014 to nearly $690 million in 2023. In contrast, Madrigal's expenses increased by a staggering 587%, from $15 million to $108 million, reflecting its rapid growth and expansion efforts.
These trends highlight the differing strategies of these two companies in navigating the pharmaceutical landscape.
Who Optimizes SG&A Costs Better? Novo Nordisk A/S or Alkermes plc
Operational Costs Compared: SG&A Analysis of AstraZeneca PLC and Alkermes plc
Breaking Down SG&A Expenses: argenx SE vs Madrigal Pharmaceuticals, Inc.
Breaking Down SG&A Expenses: Neurocrine Biosciences, Inc. vs Alkermes plc
Operational Costs Compared: SG&A Analysis of BioMarin Pharmaceutical Inc. and Alkermes plc
Selling, General, and Administrative Costs: Sarepta Therapeutics, Inc. vs Madrigal Pharmaceuticals, Inc.
Comparing SG&A Expenses: Madrigal Pharmaceuticals, Inc. vs Opthea Limited Trends and Insights
Madrigal Pharmaceuticals, Inc. vs Bausch Health Companies Inc.: SG&A Expense Trends
Madrigal Pharmaceuticals, Inc. or Celldex Therapeutics, Inc.: Who Manages SG&A Costs Better?
Alkermes plc and CRISPR Therapeutics AG: SG&A Spending Patterns Compared
Who Optimizes SG&A Costs Better? Alkermes plc or Vericel Corporation
Comparing SG&A Expenses: Alkermes plc vs Travere Therapeutics, Inc. Trends and Insights